|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34,350.45 INR | +0.42% |
|
-1.00% | +15.48% |
| 15/05 | Abbott India's quarterly profit climbs 28% on strong demand | RE |
| 15/05 | Abbott India Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability (Composite) | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
| 847.23Cr | ||||||
| 70TCr | ||||||
| 37TCr | ||||||
| 34TCr | ||||||
| 31TCr | ||||||
| 26TCr |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition